Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif - PubMed (original) (raw)
. 2007 Jul 13;282(28):20534-43.
doi: 10.1074/jbc.M611782200. Epub 2007 May 14.
Affiliations
- PMID: 17502379
- DOI: 10.1074/jbc.M611782200
Free article
Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif
Stephen C Land et al. J Biol Chem. 2007.
Free article
Abstract
Tumors that form as a result of heightened mammalian target of rapamycin (mTOR) signaling are highly vascularized. This process of angiogenesis is regulated through hypoxia-inducible factor (HIF)-mediated transcription of angiogenic factors. It is recognized that inhibition of mTOR with rapamycin can diminish the process of angiogenesis. Our work shows that activation of mTOR by Ras homologue enriched in brain (Rheb) overexpression potently enhances the activity of HIF1alpha and vascular endothelial growth factor (VEGF)-A secretion during hypoxia, which is reversed with rapamycin. Mutants of Rheb, which do not bind guanine nucleotide (D60K, D60V, N119I, and D122N) and are unable to activate mTOR, inhibit the activity of HIF when overexpressed. We show that regulatory associated protein of mTOR (Raptor) interacts with HIF1alpha and requires an mTOR signaling (TOS) motif located in the N terminus of HIF1alpha. Furthermore, a mutant of HIF1alpha lacking this TOS motif dominantly impaired HIF activity during hypoxia and was unable to bind to the co-activator CBP/p300. Rapamycin treatments do not affect the stability of HIF1alpha and modulate HIF activity via a Von Hippel-Lindau (VHL)-independent mechanism. We demonstrate that the high levels of HIF activity in cells devoid of TSC2 can be reversed by treatments with rapamycin or the readdition of TSC2. Our work explains why human cancers with aberrant mTOR signaling are prone to angiogenesis and suggests that inhibition of mTOR with rapamycin might be a suitable therapeutic strategy.
Similar articles
- The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.
Smith EM, Finn SG, Tee AR, Browne GJ, Proud CG. Smith EM, et al. J Biol Chem. 2005 May 13;280(19):18717-27. doi: 10.1074/jbc.M414499200. Epub 2005 Mar 16. J Biol Chem. 2005. PMID: 15772076 - PDK4 protein promotes tumorigenesis through activation of cAMP-response element-binding protein (CREB)-Ras homolog enriched in brain (RHEB)-mTORC1 signaling cascade.
Liu Z, Chen X, Wang Y, Peng H, Wang Y, Jing Y, Zhang H. Liu Z, et al. J Biol Chem. 2014 Oct 24;289(43):29739-49. doi: 10.1074/jbc.M114.584821. Epub 2014 Aug 27. J Biol Chem. 2014. PMID: 25164809 Free PMC article. - Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis.
Neuman NA, Henske EP. Neuman NA, et al. EMBO Mol Med. 2011 Apr;3(4):189-200. doi: 10.1002/emmm.201100131. Epub 2011 Mar 16. EMBO Mol Med. 2011. PMID: 21412983 Free PMC article. Review. - Molecular mechanisms through which amino acids mediate signaling through the mammalian target of rapamycin.
Kimball SR, Jefferson LS. Kimball SR, et al. Curr Opin Clin Nutr Metab Care. 2004 Jan;7(1):39-44. doi: 10.1097/00075197-200401000-00008. Curr Opin Clin Nutr Metab Care. 2004. PMID: 15090902 Review.
Cited by
- 22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXRα.
Na TY, Han YH, Ka NL, Park HS, Kang YP, Kwon SW, Lee BH, Lee MO. Na TY, et al. J Pathol. 2015 Apr;235(5):710-20. doi: 10.1002/path.4494. Epub 2015 Jan 5. J Pathol. 2015. PMID: 25557254 Free PMC article. - Clinical and Pre-Clinical Evidence of Carbonic Anhydrase IX in Pancreatic Cancer and Its High Expression in Pre-Cancerous Lesions.
Strapcova S, Takacova M, Csaderova L, Martinelli P, Lukacikova L, Gal V, Kopacek J, Svastova E. Strapcova S, et al. Cancers (Basel). 2020 Jul 22;12(8):2005. doi: 10.3390/cancers12082005. Cancers (Basel). 2020. PMID: 32707920 Free PMC article. Review. - mTOR activates hypoxia-inducible factor-1α and inhibits neuronal apoptosis in the developing rat brain during the early phase after hypoxia-ischemia.
Chen H, Xiong T, Qu Y, Zhao F, Ferriero D, Mu D. Chen H, et al. Neurosci Lett. 2012 Jan 24;507(2):118-23. doi: 10.1016/j.neulet.2011.11.058. Epub 2011 Dec 8. Neurosci Lett. 2012. PMID: 22178140 Free PMC article. - Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD. Wang Z, et al. Semin Cancer Biol. 2015 Dec;35 Suppl(Suppl):S224-S243. doi: 10.1016/j.semcancer.2015.01.001. Epub 2015 Jan 16. Semin Cancer Biol. 2015. PMID: 25600295 Free PMC article. Review. - Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma.
Jung J, Zhang Y, Celiku O, Zhang W, Song H, Williams BJ, Giles AJ, Rich JN, Abounader R, Gilbert MR, Park DM. Jung J, et al. Cancer Res. 2019 Oct 15;79(20):5218-5232. doi: 10.1158/0008-5472.CAN-19-0198. Epub 2019 Sep 5. Cancer Res. 2019. PMID: 31488423 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous